Dijon, France

Veronique Cro-Cq

This inventor holds 2 USPTO granted patents. Top assignee: Aventis Pharma S.a.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Veronique Cro-Cq. Retrieved from https://idiyas.com/inventor/veronique-cro-cq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Veronique Cro-Cq: Innovator in Therapeutic Compounds

Introduction

Veronique Cro-Cq is a notable inventor based in Dijon, France. She has made significant contributions to the field of medicinal chemistry, particularly in the development of therapeutic compounds. With a total of 2 patents to her name, her work has the potential to impact the pharmaceutical industry positively.

Latest Patents

Her latest patents include innovative derivatives of octahydro-6,10-dioxo-6H-pyridazino [1,2-a] [1,2] diazepine-1-carboxylic acid. These patents detail the preparation process and the use of these compounds in creating therapeutically active substances. The compounds described in her patents can be utilized for preparing active principles for medicines, showcasing her commitment to advancing healthcare solutions.

Career Highlights

Veronique Cro-Cq is currently associated with Aventis Pharma S.A., where she continues to explore new avenues in drug development. Her expertise in medicinal chemistry has positioned her as a valuable asset in her field.

Collaborations

Throughout her career, she has collaborated with esteemed colleagues, including Colette Colladant and John Patrick Larkin. These partnerships have fostered a collaborative environment that enhances innovation and research.

Conclusion

Veronique Cro-Cq's contributions to the field of therapeutic compounds exemplify her dedication to advancing medicine. Her innovative patents and collaborative efforts highlight her role as a key figure in pharmaceutical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…